Main content

    CPMC Neuroscience Peer-Reviewed Publications

    Charles Cobbs, M.D.

    • Ammirati M, Cobbs CS, Linskey ME, Paleologos NA, Ryken TC, Burri SH, et al. The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. Jan;96(1):85-96.

    • Char DH, Barakos JA, Cobbs CS, Shiel MJ. Fibrous dysplasia. Orbit. Aug;29(4):216-8.

    • Gaspar LE, Mehta MP, Patchell RA, Burri SH, Robinson PD, Morris RE, Cobbs CS, et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. Jan;96(1):17-32.

    • Harkins LE, Matlaf LA, Soroceanu L, Klemm K, Britt WJ, Wang W, Bland KI, Cobbs CS. Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Herpesviridae.1(1):8.

    • Kalkanis SN, Kondziolka D, Gaspar LE, Burri SH, Asher AL, Cobbs CS, et al. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. Jan;96(1):33-43.

    • Linskey ME, Andrews DW, Asher AL, Burri SH, Kondziolka D, Robinson PD, Cobbs CS, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. Jan;96(1):45-68.

    • Mehta MP, Paleologos NA, Mikkelsen T, Robinson PD, Ammirati M, Andrews DW, Cobbs CS, et al. The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. Jan;96(1):71-83.

    • Mikkelsen T, Paleologos NA, Robinson PD, Ammirati M, Andrews DW, Asher AL, Cobbs CS et al. The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. Jan;96(1):97-102.

    • Olson JJ, Paleologos NA, Gaspar LE, Robinson PD, Morris RE, Ammirati M, Cobbs CS et al. The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics. J Neurooncol. Jan;96(1):115-42.

    • Ryken TC, McDermott M, Robinson PD, Ammirati M, Andrews DW, Asher AL, Cobbs CS et al. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncl. Jan;96(1):103-14.

    Jonathan Katz, M.D.

    • Woolley SC, Moore DH, Katz JS. Insight in ALS: Awareness of behavioral change in patients with and without FTD. Amyotroph Lateral Scler.11(1-2):52-6.

    • Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, Katz JS. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. May 3;11(3):303-11.

    • Zhang R, Hadlock KG, Do H, Yu S, Honrada R, Champion S, Forshew D, Madison C, Katz J, Miller RG, McGrath MS. Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS). 2010 J Neuroimmunol. Jan;230(1-2):114-23.

    • Cudkowicz ME, Katz J, Moore DH, O’Neill G, Glass JD, Mitsumoto H, Appel S, Ravina B, Kieburtz K, Shoulson I, Kaufmann P, Khan J, Simpson E, Shefner J, Levin B, Cwik V, Schoenfeld D, Aggarwal S, McDermott MP, Miller RG. Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010 May 3;11(3):259-65.

    Kenneth Laxer, M.D.

    • Chang EF, Quigg M, Oh MC, Dillon WP, Ward MM, Laxer KD, et al. Predictors of efficacy after stereotactic radiosurgery for medial temporal lobe epilepsy. Neurology. Jan 12;74(2):165-72.

    • Mueller SG, Ebel A, Barakos J, Scanlon C, Cheong I, Finlay D, Laxer KD. Widespread extrahippocampal NAA/(Cr+Cho) abnormalities in TLE with and without mesial temporal sclerosis. J Neurol. Apr;258(4):603-12.

    • Mueller SG, Laxer KD, Barakos J, Cheong I, Finlay D, Garcia P, et al. Involvement of the thalamocortical network in TLE with and without mesiotemporal sclerosis. Epilepsia. Aug;51(8):1436-45.

    • Raj A, Mueller SG, Young K, Laxer KD, Weiner M. Network-level analysis of cortical thickness of the epileptic brain. Neuroimage. Oct 1;52(4):1302-13.

    Catherine Madison, M.D.

    • Zhang R, Hadlock KG, Do H, Yu S, Honrada R, Champion S, Forshew D, Madison C, Katz J, Miller RG, McGrath MS. Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS). 2010 J Neuroimmunol. Jan;230(1-2):114-23.

    Robert Miller, M.D.


    • Zhang R, Hadlock KG, Do H, Yu S, Honrada R, Champion S, Forshew D, Madison C, Katz J, Miller RG, McGrath MS. Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS). 2010 J Neuroimmunol. Jan;23

    • Rule RR, Schuff N, Miller RG, Weiner MW. Gray matter perfusion correlates with disease severity in ALS. Neurology. 2010 Mar 9;74(10):821-7.

    • Cudkowicz ME, Katz J, Moore DH, O’Neill G, Glass JD, Mitsumoto H, Appel S, Ravina B, Kieburtz K, Shoulson I, Kaufmann P, Khan J, Simpson E, Shefner J, Levin B, Cwik V, Schoenfeld D, Aggarwal S, McDermott MP, Miller RG. Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010 May 3;11(3):259-65.

    • Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, Katz JS. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. 2010 May 3;11(3):303-11.

    Michael Rowbotham, M.D.


    • Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, Rowbotham MC, et al. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain. Sep;11(9):807-29.

    • Dworkin RH, Turk DC, Katz NP, Rowbotham MC, Peirce-Sandner S, Cerny I, et al. Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION. Pain. Mar;152(3 Suppl):S107-15.

    • Haanpaa M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, Rowbotham MC, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain. Jan;152(1):14-27.

    • Moore RA, Derry S, McQuay HJ, Straube S, Aldington D, Wiffen P, Rowbotham MC. Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences. Pain. May;149(2):173-6.

    • Petersen KL, Rice FL, Farhadi M, Reda H, Rowbotham MC. Natural history of cutaneous innervation following herpes zoster. Pain. Jul;150(1):75-82.

    • Petersen KL, Rowbotham MC. Natural history of sensory function after herpes zoster. Pain. Jul;150(1):83-92.

    • Rowbotham MC. Pain’s policy on the spinal administration of drugs. Pain. Jun;149(3):415-6.

    Susan Woolley, Ph.D.

    • Woolley SC, Moore DH, Katz JS. Insight in ALS: Awareness of behavioral change in patients with and without FTD. Amyotroph Lateral Scler.11(1-2):52-6.